Skip to main content
Clinical Trials/CTRI/2025/07/090674
CTRI/2025/07/090674
Not Applicable
Not Applicable

Effectiveness of Extracorporeal Shockwave Therapy on Pain and Morphological Characteristics of Patellofemoral Pain Syndrome

Dr Ehsanur Rahman1 site in 1 country60 target enrollmentStarted: July 26, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not Applicable
Sponsor
Dr Ehsanur Rahman
Enrollment
60
Locations
1
Primary Endpoint
Pain which is measured by Pressure Algometer, Anterior Knee Pain Scale , Knee injury and Osteoarthritis Outcome Score - Patellofemoral subscale and Morphological Characteristics which is measured by Musculoskeletal Ultrasonography imaging

Overview

Brief Summary

The purpose of this single centered, participant and assessor blinded parallel group Randomized Clinical Trial is to examine the effectiveness of ESWT with isometric exercises against UST with isometric exercises to improve pain and morphological characteristics which are primary outcome that measures through Pressure Algometer or Anterior Knee Pain Scale and USG and functional activity which is secondary outcome that measures through Lower Extremity Functional Scale with the patient of Patellofemoral Pain Syndrome.

The expected result of this study will be the ESWT with isometric exercise will be effective for pain reducing and significant changes can be found in morphological characteristics.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Outcome Assessor Blinded

Eligibility Criteria

Ages
19.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Men and women aged between 19 to 60 years.
  • Individuals with Patellofemoral Pain having a Kujala Score of less than
  • Presence of any soft tissue lesion or tendinosis in the quadriceps tendon as noted in musculoskeletal ultrasonography (MSK USG).
  • Presence of any soft tissue lesion or tendinosis in the patellar tendon as noted in musculoskeletal ultrasonography (MSK USG).
  • Presence of patellofemoral degenerative changes as noted in musculoskeletal ultrasonography (MSK USG).
  • Able to walk independently without the use of walking aids.

Exclusion Criteria

  • Patients who contraindicated to ESWT such as pregnant, blood clotting disorders, oral anti coagulants, received steroid injections within 6 weeks, pacemaker fitted, tumor, fracture dislocation, history of tendon rupture (Enfield Osteopathic Field) Individuals with Infrapatellar bursitis, fat pad impingement, patellar tendinopathy injuries, Osgood Schlatter syndrome.
  • (Enfield Osteopathic Clinic) History of surgery with past 6 months Patients with neurological conditions.

Outcomes

Primary Outcomes

Pain which is measured by Pressure Algometer, Anterior Knee Pain Scale , Knee injury and Osteoarthritis Outcome Score - Patellofemoral subscale and Morphological Characteristics which is measured by Musculoskeletal Ultrasonography imaging

Time Frame: 4 Weeks

Secondary Outcomes

  • Secondary outcome will be Functional Activity which is measured by Lower Extremity Functional Scale(4 Weeks)

Investigators

Sponsor
Dr Ehsanur Rahman
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Mubashsira Islam Raisa

Jashore University of Science and Technology

Study Sites (1)

Loading locations...

Similar Trials